HK1187609A1 - Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase inhibitors - Google Patents
Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase inhibitorsInfo
- Publication number
- HK1187609A1 HK1187609A1 HK14100511.4A HK14100511A HK1187609A1 HK 1187609 A1 HK1187609 A1 HK 1187609A1 HK 14100511 A HK14100511 A HK 14100511A HK 1187609 A1 HK1187609 A1 HK 1187609A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzyl
- phenyl
- optionally substituted
- disulfanyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0510862A FR2892413B1 (fr) | 2005-10-25 | 2005-10-25 | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
FR0604030A FR2892414B1 (fr) | 2005-10-25 | 2006-05-05 | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1187609A1 true HK1187609A1 (en) | 2014-04-11 |
Family
ID=36582065
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09104545.3A HK1125648A1 (en) | 2005-10-25 | 2009-05-19 | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
HK14100511.4A HK1187609A1 (en) | 2005-10-25 | 2009-05-19 | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09104545.3A HK1125648A1 (en) | 2005-10-25 | 2009-05-19 | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors |
Country Status (13)
Country | Link |
---|---|
US (1) | US8247608B2 (ja) |
JP (1) | JP5177889B2 (ja) |
CN (2) | CN103351377B (ja) |
AT (1) | ATE521601T1 (ja) |
BR (1) | BRPI0617918B8 (ja) |
CA (1) | CA2627211C (ja) |
DK (1) | DK1940818T3 (ja) |
ES (2) | ES2369256T3 (ja) |
FR (2) | FR2892413B1 (ja) |
HK (2) | HK1125648A1 (ja) |
IL (1) | IL191069A (ja) |
NO (1) | NO20082329L (ja) |
ZA (1) | ZA200803643B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
FR2934267B1 (fr) | 2008-07-23 | 2010-08-13 | Pharmaleads | Derives aminophosphiniques utiles dans le traitement de la douleur |
FR2946650B1 (fr) | 2009-06-16 | 2011-08-19 | Sanofi Aventis | Esters derives d'azetidines, leur preparation et leur application en therapeutique. |
WO2013026942A1 (en) | 2011-08-25 | 2013-02-28 | The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Tubulin binding agents |
JP2013043885A (ja) * | 2011-08-26 | 2013-03-04 | Kansai Bunri Sogo Gakuen | デヒドロアミノ酸含有グリセロール誘導体 |
CN102633748A (zh) * | 2012-03-22 | 2012-08-15 | 盛世泰科生物医药技术(苏州)有限公司 | 2-甲酸乙酯-5-溴-1,3,4-噻二唑的合成方法 |
FR2997081B1 (fr) | 2012-10-23 | 2015-11-27 | Pharmaleads | Inhibiteurs mixtes de l'aminopeptidase n et de la neprilysine |
FR2997080B1 (fr) * | 2012-10-23 | 2015-11-27 | Pharmaleads | Inhibiteurs de neprilysine |
TWI712582B (zh) * | 2015-10-14 | 2020-12-11 | 法商領先藥物公司 | 用來製備(5s,10s)-10-苄基-16-甲基-11,14,18-三側氧基-15,17,19-三氧雜-2,7,8-三噻基-12-氮二十一烷基-5-銨基(e)-3-羧基丙烯酸鹽的工業方法 |
EP3488666B1 (en) | 2016-07-22 | 2022-04-13 | Lutron Technology Company LLC | Modular lighting panel |
CN107778205B (zh) * | 2016-08-31 | 2019-10-18 | 北京工商大学 | 一种制备3-甲硫基丙胺的方法 |
FR3077201B1 (fr) | 2018-01-26 | 2020-01-17 | Pharmaleads | Derives aminoacides contenant un groupement disulfanyle sous forme d'un inhibiteur de nep et d'apn pour la prevention et le traitement des douleurs relatives au nerf trijumeau |
TW202029962A (zh) * | 2018-10-26 | 2020-08-16 | 法商量子基因科技有限公司 | 胺肽酶a抑制劑及包含其的醫藥組合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518088B1 (fr) | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
FR2605004B1 (fr) | 1986-09-25 | 1989-01-13 | Centre Nat Rech Scient | Nouveaux derives d'amino-acides, leur procede de preparation et composition pharmaceutiques les contenant |
FR2651229B1 (fr) * | 1989-08-24 | 1991-12-13 | Inst Nat Sante Rech Med | Nouveaux derives d'amino-acides, leur procede de preparation et leur application therapeutique. |
US20050025791A1 (en) * | 2002-06-21 | 2005-02-03 | Julius Remenar | Pharmaceutical compositions with improved dissolution |
US20030199496A1 (en) * | 2002-04-22 | 2003-10-23 | Simon David Lew | Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use |
RU2348629C2 (ru) * | 2003-05-30 | 2009-03-10 | Ф.Хоффманн-Ля Рош Аг | Производные бензотиазола и их применение при лечении заболеваний, связанных с аденозиновыми a2a-рецепторами |
-
2001
- 2001-06-20 ES ES01946659T patent/ES2369256T3/es not_active Expired - Lifetime
-
2005
- 2005-10-25 FR FR0510862A patent/FR2892413B1/fr not_active Expired - Fee Related
-
2006
- 2006-05-05 FR FR0604030A patent/FR2892414B1/fr active Active
- 2006-10-24 CN CN201310280813.6A patent/CN103351377B/zh active Active
- 2006-10-24 CA CA2627211A patent/CA2627211C/fr active Active
- 2006-10-24 JP JP2008537082A patent/JP5177889B2/ja active Active
- 2006-10-24 BR BRPI0617918A patent/BRPI0617918B8/pt active IP Right Grant
- 2006-10-24 CN CN2006800442299A patent/CN101316833B/zh active Active
- 2006-10-24 AT AT06807506T patent/ATE521601T1/de not_active IP Right Cessation
- 2006-10-24 US US12/084,091 patent/US8247608B2/en active Active
- 2006-10-24 ES ES06807506T patent/ES2369257T3/es active Active
- 2006-10-24 DK DK06807506.8T patent/DK1940818T3/da active
-
2008
- 2008-04-24 ZA ZA200803643A patent/ZA200803643B/xx unknown
- 2008-04-27 IL IL191069A patent/IL191069A/en active IP Right Grant
- 2008-05-22 NO NO20082329A patent/NO20082329L/no not_active Application Discontinuation
-
2009
- 2009-05-19 HK HK09104545.3A patent/HK1125648A1/xx unknown
- 2009-05-19 HK HK14100511.4A patent/HK1187609A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK1940818T3 (da) | 2011-11-21 |
JP2009513600A (ja) | 2009-04-02 |
FR2892414A1 (fr) | 2007-04-27 |
CN101316833B (zh) | 2013-08-14 |
NO20082329L (no) | 2008-05-22 |
FR2892413A1 (fr) | 2007-04-27 |
HK1125648A1 (en) | 2009-08-14 |
ATE521601T1 (de) | 2011-09-15 |
US20090131509A1 (en) | 2009-05-21 |
FR2892414B1 (fr) | 2010-11-26 |
IL191069A (en) | 2014-05-28 |
ES2369257T3 (es) | 2011-11-28 |
CA2627211C (fr) | 2014-07-29 |
ZA200803643B (en) | 2009-02-25 |
BRPI0617918B8 (pt) | 2021-05-25 |
CA2627211A1 (fr) | 2007-05-03 |
IL191069A0 (en) | 2008-12-29 |
CN103351377B (zh) | 2015-05-13 |
BRPI0617918A2 (pt) | 2011-08-09 |
BRPI0617918B1 (pt) | 2020-09-08 |
JP5177889B2 (ja) | 2013-04-10 |
CN101316833A (zh) | 2008-12-03 |
CN103351377A (zh) | 2013-10-16 |
US8247608B2 (en) | 2012-08-21 |
ES2369256T3 (es) | 2011-11-28 |
FR2892413B1 (fr) | 2008-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1125648A1 (en) | Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors | |
CY1117449T1 (el) | Φαινυλιουχα ν-ακυλο παραγωγα αμινων και αμινοξεων, μεθοδοι για την παραγωγη αυτων, μια φαρμακευτικη συνθεση και η χρηση αυτων | |
PL1780197T3 (pl) | 5-podstawione-2-fenyloaminobenzamidy jako inhibitory MEK | |
PA8620301A1 (es) | Inhibidores heterociclil amino de 11-beta-hidrosiesteroide deshidrogenasa tipo 1 | |
TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
BRPI0415960A (pt) | composto ou um sal do mesmo, pró-droga de um composto, agente farmacêutico, inibidor de peptidase, composto ou um sal do mesmo, pró-droga de um composto, agente farmacêutico, inibidor de peptidase, uso de um composto,e, método para produzir um composto | |
SG159388A1 (en) | Antibacterial agents | |
MXPA05005146A (es) | Indolpiridinio sustituido como compuestos antiinfecciosos. | |
BR112012003592B8 (pt) | composição farmacêutica contendo derivado de quinolina | |
CO5720995A2 (es) | Compuesto novedoso | |
TW200734309A (en) | Water-soluble benzoazepine compound and its pharmaceutical composition | |
MX2009003739A (es) | Derivados de hidrobenzamida como inhibidores de hsp90. | |
PL2262751T3 (pl) | Zastosowanie kwasu alkanosulfonowego jako środka oczyszczającego z cementów, zapraw i betonów | |
PE20080835A1 (es) | Derivados novedosos de aminopiridina que tienen accion inhibidora selectiva sobre aurora a | |
UY31917A (es) | Compuestos de pirido-pirimidina inhibidores de mtor, composiciones farmaceuticas que los comprenden, procesos para su preparación y su uso como medicamento. | |
GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
TN2009000167A1 (en) | Crystalline potassium salt of lipoxin a4 analogs | |
EA200600878A1 (ru) | Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar ) | |
CO6220854A2 (es) | Nuevo procedimiento para la preparacion de 4,4´-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona) | |
EP2417115A4 (en) | FATTY ACID AMIDE HYDROLASE INHIBITORS | |
AR075308A1 (es) | Composicion para controlar fitoenfermedades y metodo para controlar fitoenfermedades | |
MXPA05009688A (es) | Derivados de naftiridina como agentes antibacterianos. | |
DE602006007483D1 (ja) | ||
TW200720262A (en) | Novel compounds ii | |
ATE540026T1 (de) | Hydroxyphenylsulfonsäureamide als antiapoptotische bcl-inhibitoren |